The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pneumomediastinum
Publications
Pneumomediastinum, pneumopericardium and subcutaneous emphysema following acute lymphoblastic leukemia and chemotherapy: A case report.
Caspian journal of internal medicine 2021;12;S379-S382 — 2021 — S379-S382
Pneumomediastinum after acute lymphoblastic leukemia and chemotherapy?
World journal of clinical cases 2014 May 16;2;170-1 — 2014 May 16 — 170-1
Pneumomediastinum as a complication to treatment of mediastinal (thymic) large B-cell lymphoma.
Acta radiologica (Stockholm, Sweden : 1987) 2005 Jul;46;371-3 — 2005 Jul — 371-3
Pneumomediastinum: a rare, impressive but benign complication of chemotherapy-induced emesis in children.
Medical and pediatric oncology 1998 Sep;31;182-4 — 1998 Sep — 182-4